Tag: San Francisco

Biopharma VC Investing: Reporter's JPM Notebook InsightsSAN FRANCISCO — The J.P. Morgan Healthcare Conference isn’t just a venue for companies in the industry to...

Optimizing GLP-1 Drug Efficiency and Affordability in Virtual Care: JPM Week HighlightsThe J.P. Morgan Health Care conference in San Francisco this week was abuzz...

Alignment Healthcare Stands Strong Amidst Industry TurmoilIn the midst of the chaos at the J.P. Morgan Healthcare Conference, one company stands out - Alignment...

Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures...

Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech...

Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir...

Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs...

Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the...

Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in...